Free Trial
NASDAQ:RVMDW

Revolution Medicines (RVMDW) Stock Price, News & Analysis

$0.12 -0.05 (-29.20%)
As of 01:38 PM Eastern

About Revolution Medicines Stock (NASDAQ:RVMDW)

Key Stats

Today's Range
$0.12
$0.15
50-Day Range
$0.10
$0.25
52-Week Range
$0.05
$0.80
Volume
935 shs
Average Volume
17,934 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Receive RVMDW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter.

RVMDW Stock News Headlines

Revolution Medicines (RVMD) Receives a Buy from Barclays
Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
Revolution Medicines (RVMD) Gets a Buy from Bank of America Securities
See More Headlines

RVMDW Stock Analysis - Frequently Asked Questions

Revolution Medicines' stock was trading at $0.18 at the start of the year. Since then, RVMDW stock has decreased by 33.3% and is now trading at $0.12.
View the best growth stocks for 2025 here
.

Revolution Medicines' top institutional shareholders include Concourse Financial Group Securities Inc..

Shares of RVMDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:RVMDW
Fax
N/A
Employees
378
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$742,000.00

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NASDAQ:RVMDW) was last updated on 2/25/2025 by MarketBeat.com Staff
From Our Partners